Benzinga | Nov 10, 2020 04:16PM EST

Health Catalyst Q3 EPS $(0.21) Beats $(0.27) Estimate, Sales $47.19M Beat $44.59M Estimate

Health Catalyst (NASDAQ:HCAT) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.27) by 22.22 percent. This is a 22.22 percent increase over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $47.19 million which beat the analyst consensus estimate of $44.59 million by 5.83 percent. This is a 19.70 percent increase over sales of $39.42 million the same period last year.